Jiangsu Yuyue Medical Equipment & Supply 鱼跃医疗
17 significant filings since 29 May 2026: 14 on buyback and 3 on dividend. The latest, on 18 Sep 2026: 关于回购股份注销完成暨股份变动的公告.
自 29 May 2026 起有 17 份重大公告：buyback 14 份、dividend 3 份。最新一份（18 Sep 2026）：关于回购股份注销完成暨股份变动的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 25 Aug 2020 | 新时代证券 | 沈瑞 | Buy 买入 | ▼ | Outperform 增持 |
| 18 Aug 2020 | 群益证券 | 王睿哲 | Buy 买入 | ▼ | Outperform 增持 |
| 2 Feb 2019 | 群益证券 | 王睿哲 | Outperform 增持 | ▲ | Buy 买入 |
| 14 Aug 2018 | 群益证券 | 王睿哲 | Buy 买入 | ▼ | Outperform 增持 |
| 23 Aug 2017 | 东吴证券 | 焦德智,全铭 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 杜向阳,雷瑞 | Unrated | 26 Aug 2026 | 2 | — |
| 东吴证券 | 朱国广 | Buy 买入 | 25 Aug 2026 | 1 | — |
| 国信证券 | 陈曦炳,彭思宇,贾瑞祥 | Outperform 增持 | 24 Aug 2026 | 1 | — |
| 国金证券 | 甘坛焕,何冠洲 | Buy 买入 | 22 Aug 2026 | 3 | — |
| 太平洋 | 谭紫媚,李啸岩 | Buy 买入 | 9 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 8 reports. 每行为该券商近十二个月的最新研报；8 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。